Last reviewed · How we verify
Prevention of Neonatal Hemorrhagic Disease
Approved treatments
- phytomenadione · Instituto Mexicano del Seguro Social
- Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Neonatal Hemorrhagic Disease patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Neonatal Hemorrhagic Disease treatment landscape brief
- Prevention of Neonatal Hemorrhagic Disease treatment updates RSS
Frequently asked questions about Prevention of Neonatal Hemorrhagic Disease
What drugs treat Prevention of Neonatal Hemorrhagic Disease?
Tracked treatments include phytomenadione, Phylloquinone.
What is the treatment for Prevention of Neonatal Hemorrhagic Disease?
Standard treatment for Prevention of Neonatal Hemorrhagic Disease includes phytomenadione, Phylloquinone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Neonatal Hemorrhagic Disease patent cliff · Prevention of Neonatal Hemorrhagic Disease CI report
- Treatment: phytomenadione · Instituto Mexicano del Seguro Social
- Treatment: Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing